mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |